Abstract
Introduction (with the objective): The organization of Pharmaceutical Assistance in the Unified Health System (SUS) requires instruments capable of guiding the pharmaceutical assistance cycle.1 ⁻ ⁴ In this context, the Alagoas State List of Medicines (RESME/AL) was developed as a strategic tool to consolidate the medicines used in the state network, improve access, and support management decisions based on technical, epidemiological, and care criteria.⁵ ⁻ ⁸ This construction aligns with national and international recommendations on lists of essential medicines, which should consider the priority health needs of the population, the epidemiological profile, evidence of efficacy and safety, availability in services, and the rational use of public resources.³,⁵ ⁻ ⁷ . To report on the construction process of RESME/AL, describing its methodology, the main results achieved, and its contribution to the organization of Pharmaceutical Assistance in the state. Description: This is a descriptive study, developed from the process of elaborating the RESME/AL (State Essential Medicines List), coordinated by the Health Technology Assessment Commission and the Multiprofessional Working Group. The study was conducted between 2024 and 2025, through the analysis of medicines and supplies in use in the state network, a survey of the demands of health services, evaluation of inclusion and exclusion requests, verification of availability in services, pharmaceutical form, concentration, ATC classification, component of Pharmaceutical Assistance, and dispensing location. The process encompassed the Basic, Strategic, and Specialized components, in addition to items from the hospital network. The analysis identified 853 items, distributed among medicines and supplies organized by component of Pharmaceutical Assistance, availability in the state network, and ATC classification. Regarding the components, there was a predominance of items without a specific component, linked to the hospital network (290), followed by the Specialized Component (279), Basic Component (173), and Strategic Component (99). Items classified simultaneously as Basic and Strategic (10), Specialized and Strategic (1), and Basic and Specialized (1) were also identified. As for availability within the network, the highest concentration occurred in the Hospital Network (464), followed by CEAF (251), Primary Care (36), Specialized Primary Care (30), and UDM (30). According to the ATC classification, the highest concentration was found in groups J — systemic anti-infectives (147); N — nervous system (133); C — cardiovascular system (92); A — alimentary tract and metabolism (81); and L — antineoplastics and immunomodulators (70). Also identified were 64 items related to group B — blood and hematopoietic organs, 44 to R — respiratory system, 34 to M — musculoskeletal system, 32 to D — dermatological, 32 to H — systemic hormonal preparations, 32 to V — various, 30 to G — genitourinary system and sex hormones, 26 to P — antiparasitics, insecticides and repellents, 25 to S — sensory organs, and 11 items without a defined ATC classification or classified as Not Available. Conclusion: These data demonstrate the scope of RESME/AL as a technical instrument for organizing Pharmaceutical Assistance, allowing visualization of the therapeutic composition of the network, the distribution of medicines among components and services, in addition to supporting the planning of acquisitions, annual programming, inventory management and strengthening access in the SUS in Alagoas.
